Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Thirman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biology|July 21, 2001
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesisR T Luo, C Lavau, C Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Developmental analysis and subcellular localization of the murine homologue of ELLM J Thirman, E B Diskin, S S Bin, et al.
Blood|June 1, 1993
Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Genes, Chromosomes & Cancer|April 1, 1996
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell lineS Tanabe, N J Zeleznik-Le, H Kobayashi, et al.
Blood|March 1, 1996
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sitesP L Broeker, H G Super, M J Thirman, et al.
Genes, Chromosomes & Cancer|August 1, 1993
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Blood|July 15, 1993
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: a possible role in atherogenesisM J Thirman, J H Albrecht, M A Krueger, et al.
Blood|December 15, 1993
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase IIH J Super, N R McCabe, M J Thirman, et al.
The New England Journal of Medicine|September 23, 1993
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocationsM J Thirman, H J Gill, R C Burnett, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|July 21, 2001
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesisR T Luo, C Lavau, C Du, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Developmental analysis and subcellular localization of the murine homologue of ELLM J Thirman, E B Diskin, S S Bin, et al.
Blood|June 1, 1993
Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Genes, Chromosomes & Cancer|April 1, 1996
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell lineS Tanabe, N J Zeleznik-Le, H Kobayashi, et al.
Blood|March 1, 1996
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sitesP L Broeker, H G Super, M J Thirman, et al.
Genes, Chromosomes & Cancer|August 1, 1993
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Blood|July 15, 1993
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: a possible role in atherogenesisM J Thirman, J H Albrecht, M A Krueger, et al.
Blood|December 15, 1993
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase IIH J Super, N R McCabe, M J Thirman, et al.
The New England Journal of Medicine|September 23, 1993
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocationsM J Thirman, H J Gill, R C Burnett, et al.
Pageof 3